Participant flow36

How many started, completed or left each group, period by period.

1 to 20 of 36

Period	Milestone	Group	Participants
INDUCTION	STARTED	Secukinumab 150mg	136
INDUCTION	STARTED	Secukinumab 300mg	272
INDUCTION	STARTED	Placebo	135
INDUCTION	STARTED	Placebo - Secukinumab 300mg	0
INDUCTION	COMPLETED	Secukinumab 150mg	134
INDUCTION	COMPLETED	Secukinumab 300mg	270
INDUCTION	COMPLETED	Placebo	133
INDUCTION	COMPLETED	Placebo - Secukinumab 300mg	0
INDUCTION	NOT COMPLETED	Secukinumab 150mg	2
INDUCTION	NOT COMPLETED	Secukinumab 300mg	2
INDUCTION	NOT COMPLETED	Placebo	2
INDUCTION	NOT COMPLETED	Placebo - Secukinumab 300mg	0
MAINTENANCE	STARTED	Secukinumab 150mg	134
MAINTENANCE	STARTED	Secukinumab 300mg	270
MAINTENANCE	STARTED	Placebo	4
MAINTENANCE	STARTED	Placebo - Secukinumab 300mg	129
MAINTENANCE	COMPLETED	Secukinumab 150mg	127
MAINTENANCE	COMPLETED	Secukinumab 300mg	266
MAINTENANCE	COMPLETED	Placebo	2
MAINTENANCE	COMPLETED	Placebo - Secukinumab 300mg	126

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03066609/flow